These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 16839328)

  • 1. Testosterone:estradiol ratio changes associated with long-term tadalafil administration: a pilot study.
    Greco EA; Pili M; Bruzziches R; Corona G; Spera G; Aversa A
    J Sex Med; 2006 Jul; 3(4):716-722. PubMed ID: 16839328
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of low testosterone on response to treatment with tadalafil 5 mg once daily for erectile dysfunction.
    Goldfischer ER; Kim ED; Seftel AD; Baygani SK; Burns PR
    Urology; 2014 Jun; 83(6):1326-33. PubMed ID: 24726311
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tadalafil is efficacious and well tolerated in the treatment of erectile dysfunction (ED) in men over 65 years of age: results from Multiple Observations in Men with ED in National Tadalafil Study in the United States.
    Sharlip ID; Shumaker BP; Hakim LS; Goldfischer E; Natanegara F; Wong DG
    J Sex Med; 2008 Mar; 5(3):716-25. PubMed ID: 18304286
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tolerance to the therapeutic effect of tadalafil does not occur during 6 months of treatment: A randomized, double-blind, placebo-controlled study in men with erectile dysfunction.
    McMahon CG; Carson CC; Fischer CJ; Wang WC; Florio VA; Bradley JD
    J Sex Med; 2006 May; 3(3):504-11. PubMed ID: 16681476
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and safety of two dosing regimens of tadalafil and patterns of sexual activity in men with diabetes mellitus and erectile dysfunction: Scheduled use vs. on-demand regimen evaluation (SURE) study in 14 European countries.
    Buvat J; van Ahlen H; Schmitt H; Chan M; Kuepfer C; Varanese L
    J Sex Med; 2006 May; 3(3):512-20. PubMed ID: 16681477
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictors of tadalafil efficacy in men with erectile dysfunction: the SURE study comparing two dosing regimens.
    Costa P; Buvat J; Holmes S; Weitckus S; Petto H; Hamidi K; Varanese L
    J Sex Med; 2006 Nov; 3(6):1050-1058. PubMed ID: 17100938
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Psychosocial outcomes and drug attributes affecting treatment choice in men receiving sildenafil citrate and tadalafil for the treatment of erectile dysfunction: results of a multicenter, randomized, open-label, crossover study.
    Dean J; Hackett GI; Gentile V; Pirozzi-Farina F; Rosen RC; Zhao Y; Warner MR; Beardsworth A
    J Sex Med; 2006 Jul; 3(4):650-661. PubMed ID: 16839321
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effectiveness of sildenafil citrate (Viagra) and tadalafil (Cialis) on sexual responses in Saudi men with erectile dysfunction in routine clinical practice.
    Ali ST
    Pak J Pharm Sci; 2008 Jul; 21(3):275-81. PubMed ID: 18614424
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factors associated with preference for sildenafil citrate and tadalafil for treating erectile dysfunction in men naïve to phosphodiesterase 5 inhibitor therapy: post hoc analysis of data from a multicentre, randomized, open-label, crossover study.
    Eardley I; Montorsi F; Jackson G; Mirone V; Chan ML; Loughney K; Vail GM; Beardsworth A
    BJU Int; 2007 Jul; 100(1):122-9. PubMed ID: 17552960
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and safety of tadalafil in men with erectile dysfunction with a high prevalence of comorbid conditions: results from MOMENTUS: multiple observations in men with erectile dysfunction in National Tadalafil Study in the US.
    Goldstein I; Kim E; Steers WD; Pryor JL; Wilde DW; Natanegara F; Wong DG; Ahuja S
    J Sex Med; 2007 Jan; 4(1):166-175. PubMed ID: 17233782
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and safety of on-demand tadalafil for the treatment of erectile dysfunction in South-East Asian men.
    Guo YL; Zhu JC; Pan TM; Ding Q; Wang YX; Cheong NF; Lim E; Shen W; Venugopalan M; Chan M
    Int J Urol; 2006 Jun; 13(6):721-7. PubMed ID: 16834650
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of Baseline Total Testosterone Level on Successful Treatment of Sexual Dysfunction in Men Taking Once-Daily Tadalafil 5 mg for Lower Urinary Tract Symptoms and Benign Prostatic Hyperplasia: An Integrated Analysis of Three Randomized Controlled Trials.
    Mulhall JP; Brock GB; Glina S; Baygani S; Donatucci CF; Maggi M
    J Sex Med; 2016 May; 13(5):843-51. PubMed ID: 27017071
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term safety and efficacy of tadalafil 5 mg dosed once daily in men with erectile dysfunction.
    Porst H; Rajfer J; Casabé A; Feldman R; Ralph D; Vieiralves LF; Esler A; Wolka AM; Klise SR
    J Sex Med; 2008 Sep; 5(9):2160-9. PubMed ID: 18557812
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Durability of response following cessation of tadalafil taken once daily as treatment for erectile dysfunction.
    Porst H; Glina S; Ralph D; Zeigler H; Wong DG; Woodward B
    J Sex Med; 2010 Oct; 7(10):3487-94. PubMed ID: 20584129
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of tadalafil treatment on erectile function recovery following bilateral nerve-sparing radical prostatectomy: a randomised placebo-controlled study (REACTT).
    Montorsi F; Brock G; Stolzenburg JU; Mulhall J; Moncada I; Patel HR; Chevallier D; Krajka K; Henneges C; Dickson R; Büttner H
    Eur Urol; 2014 Mar; 65(3):587-96. PubMed ID: 24169081
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and safety of tadalafil 20 mg on demand vs. tadalafil 5 mg once-a-day in the treatment of post-radiotherapy erectile dysfunction in prostate cancer men: a randomized phase II trial.
    Ricardi U; Gontero P; Ciammella P; Badellino S; Valentino F; Munoz F; Guarneri A; Rondi N; Moretto F; Filippi AR; Ragona R; Tizzani A
    J Sex Med; 2010 Aug; 7(8):2851-9. PubMed ID: 21711479
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and safety of tadalafil in a Western European population of men with erectile dysfunction.
    Eardley I; Gentile V; Austoni E; Hackett G; Lembo D; Wang C; Beardsworth A
    BJU Int; 2004 Oct; 94(6):871-7. PubMed ID: 15476525
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tadalafil once daily in men with erectile dysfunction: an integrated analysis of data obtained from 1913 patients from six randomized, double-blind, placebo-controlled, clinical studies.
    Porst H; Gacci M; Büttner H; Henneges C; Boess F
    Eur Urol; 2014 Feb; 65(2):455-64. PubMed ID: 24119319
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prospective, randomized, open-label, fixed-dose, crossover study to establish preference of patients with erectile dysfunction after taking the three PDE-5 inhibitors.
    Tolrà JR; Campaña JMC; Ciutat LF; Miranda EF
    J Sex Med; 2006 Sep; 3(5):901-909. PubMed ID: 16942534
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and safety of tadalafil in the treatment of Latin American men with erectile dysfunction: results of integrated analyses.
    Rubio-Aurioles E; Casabé A; Torres LO; Quinzaños L; Glina S; Filimon I; Kopernicky V; Leñero E
    J Sex Med; 2008 Aug; 5(8):1965-76. PubMed ID: 18466266
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.